The healthcare industry is ripe for disruptions.
*Stock prices used were the afternoon prices of Sept. 14, 2026. The video was published on Sept. 16, 2026.
Should you buy stock in Hims & Hers Health right now?
Before you buy stock in Hims & Hers Health, it’s worth evaluating the company’s fundamentals, growth trajectory, and current valuation against the broader healthcare landscape.
The Motley Fool’s Stock Advisor service has delivered an average return of 938% — significantly outperforming the S&P 500’s 211% over the same period.*
*Stock Advisor returns as of September 16, 2026.
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy.
Also Read
- Markel Group Retreats 18% From Its High: Evaluating the Mini-Berkshire Investment Strategy
- The Final 10 Games That Will Decide the AL Central Crown for the Guardians and White Sox
- Portuguese Tax Cuts and Pension Bonuses: Expert Analysis on Economic Impact and Structural Challenges
- Should China really be teaching Indonesia how to negotiate?
